Skip to main content
SpringerLink
Log in

Response to Tomsak, R. PDE5 inhibitors and permanent visual loss (Int J Impot Res 2005; 17: 547–549)

  • Letter to the Editor
  • Published:
International Journal of Impotence Research Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Tomsak R . PDE5 inhibitors and permanent visual loss. Int J Impot Res 2005; 17: 547–549.

    Article  CAS  Google Scholar 

  2. Boshier A, Wilton LV, Shakir SA . Evaluation of the safety of sildenafil for male erectile dysfunction: experience gained in general practice use in England in 1999. BJU Int 2004; 93: 796–801.

    Article  CAS  Google Scholar 

  3. Giuliano F, Porst H, Hedelin H, Martin-Morales A, Sobel RE, Reynolds RF et al. Cardiovascular safety of Viagra® (sildenafil citrate): results of the international men's health study. Eur Urol 2005; 4 (Suppl 3): 137.

    Google Scholar 

  4. Laties AM, Sharlip I . Ocular safety in patients using sildenafil citrate therapy for erectile dysfunction. J Sex Med 2006; 3: 12–27.

    Article  CAS  Google Scholar 

  5. Dundar SO, Topalo Gcaron Lu A, Dundar M, Kocak I . Effects of sildenafil on blue-on-yellow and white-on-white Humphrey perimetry in 3 months regular use. Eye 2005 [Epub ahead of print].

Download references

Author information

Authors and Affiliations

  1. Pfizer Ltd, Kent, UK

    S J Watt & P Primatesta

  2. Pfizer Pharmaceuticals Group, NY, New York, USA

    R Siegel

Authors
  1. S J Watt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P Primatesta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R Siegel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S J Watt.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Watt, S., Primatesta, P. & Siegel, R. Response to Tomsak, R. PDE5 inhibitors and permanent visual loss (Int J Impot Res 2005; 17: 547–549). Int J Impot Res 18, 411 (2006). https://doi.org/10.1038/sj.ijir.3901451

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijir.3901451

  • Springer Nature Limited

Search

Navigation